BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15969954)

  • 1. Pharmacodynamic comparison of pantoprazole enantiomers: inhibition of acid-related lesions and acid secretion in rats and guinea-pigs.
    Cao H; Wang MW; Sun LX; Ikejima T; Hu ZQ; Zhao WH
    J Pharm Pharmacol; 2005 Jul; 57(7):923-7. PubMed ID: 15969954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors.
    Grover JK; Vats V
    Trop Gastroenterol; 1999; 20(1):16-28. PubMed ID: 10464444
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pantoprazole. A new acid pump inhibitor against peptic ulcer and reflux esophagitis].
    Wilson BV; Knudsen T
    Ugeskr Laeger; 1996 Mar; 158(12):1695-7. PubMed ID: 8644421
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
    Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities and differences in the properties of substituted benzimidazoles: a comparison between pantoprazole and related compounds.
    Kromer W
    Digestion; 1995; 56(6):443-54. PubMed ID: 8536813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
    Dammann HG; Burkhardt F
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
    Pisegna JR; Martin P; McKeand W; Ohning G; Walsh JH; Paul J
    Am J Gastroenterol; 1999 Oct; 94(10):2874-80. PubMed ID: 10520836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pantoprazole on xenobiotic metabolizing enzymes in rat liver microsomes: a comparison with other proton pump inhibitors.
    Masubuchi N; Hakusui H; Okazaki O
    Drug Metab Dispos; 1997 May; 25(5):584-9. PubMed ID: 9152597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective chiral inversion of pantoprazole enantiomers after separate doses to rats.
    Masubuchi N; Yamazaki H; Tanaka M
    Chirality; 1998; 10(8):747-53. PubMed ID: 9803530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
    Shin JM; Sachs G
    Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of IY81149 with omeprazole in rat reflux oesophagitis.
    Kil BJ; Kim IW; Shin CY; Jeong JH; Jun CH; Lee SM; Kim DY; Huh IH; Sohn UD
    J Auton Pharmacol; 2000; 20(5-6):291-6. PubMed ID: 11350494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pantoprazole administered subcutaneously on the healing of sutured gastric incisions in rats.
    Bonin EA; Campos AC; Coelho JC; Matias JE; Malafaia O; Jonasson TH
    Eur Surg Res; 2005; 37(4):250-6. PubMed ID: 16260877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
    Pratha VS; Hogan DL; Lane JR; Williams PJ; Burton MS; Lynn RB; Karlstadt RG
    Dig Dis Sci; 2006 Jan; 51(1):123-31. PubMed ID: 16416224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
    Metz DC
    Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Takac B; Ivandić A; Pezerović D; Horvat D; Nedić P; Kotromanović Z; Maksimović Z; Vranjes Z; Males J; Jurisić-Orzen D; Vladika I; Stimac T; Mandić B
    Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The basis of differentiation of PPIs.
    Sachs G; Shin JM
    Drugs Today (Barc); 2004 Mar; 40 Suppl A():9-14. PubMed ID: 15190382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Mimusops elengi bark in experimental gastric ulcers.
    Shah PJ; Gandhi MS; Shah MB; Goswami SS; Santani D
    J Ethnopharmacol; 2003 Dec; 89(2-3):305-11. PubMed ID: 14611897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.